Ann Richmond

October 6, 2016

VA honors Richmond’s scientific contributions

Vanderbilt University cancer researcher Ann Richmond, Ph.D., has won the 2016 William S. Middleton Award, the highest honor for scientific achievement bestowed by the Biomedical Laboratory Research and Development Service of the U.S. Department of Veterans Affairs (VA).

By Bill Snyder
February 18, 2016

Combining treatments for melanoma

Combining therapies for melanoma that induce cell senescence and that activate the immune response may improve outcomes for patients.

By Leigh MacMillan
May 21, 2015

VICC Annual Retreat focuses on immunotherapy

Efforts to enable the immune system to “see” the cancer and attack the aberrant cells were the prime focus during Vanderbilt-Ingram Cancer Center’s Annual Retreat, held April 30 at the Vanderbilt University Student Life Center.

By VUMC News and Communications
January 8, 2015

Study tracks combination therapy to treat melanoma

Melanoma is the most lethal form of skin cancer, with high mortality rates. While new drugs have been approved to treat the disease, patients nearly always develop resistance to the therapies and the cancer advances.

By VUMC News and Communications
November 6, 2014

Immune cell activity and melanoma

The activity of a certain factor in immune cells is essential for an anti-tumor response, emphasizing the need to consider the effects of anti-cancer therapies on immune cells.

By VUMC News and Communications
Chancellor Nicholas S. Zeppos (left) and Faculty Senate Chair Paul Lim (right) present the 2014 Earl Sutherland Prize to Jane Landers, Gertrude Conaway Vanderbilt Professor of History. (Joe Howell/Vanderbilt)
August 22, 2014

Landers, Fuchs win awards at Fall Faculty Assembly

An international expert on slavery and emancipation during the 18th and 19th centuries was awarded the prestigious Earl Sutherland Prize for Achievement in Research during Vanderbilt University’s Fall Faculty Assembly.

By VUMC News and Communications
May 29, 2014

Faculty meeting highlights VUSM achievements

Despite a challenging health care landscape, Vanderbilt University Medical Center continues to advance the highest-quality patient care, train the next generation of physician leaders and push forward the frontiers of biomedical science.
By Bill Snyder
May 23, 2013

VICC hosts cancer researchers during annual retreat

The role of inflammation in gastrointestinal cancer development was a prominent theme among guest speakers during the Vanderbilt-Ingram Cancer Center annual retreat held at the Vanderbilt Student Life Center.
By VUMC News and Communications
October 18, 2012

Nobel in Chemistry reveals VU ties that bind

Several Vanderbilt researchers have collaborated with this year's Nobel Chemistry winners.
By Bill Snyder
September 27, 2012

Target acquired for aggressive tumor

New therapeutic target for angiosarcoma – an aggressive, highly fatal tumor of the blood vessels – identified.
By VUMC News and Communications
April 26, 2012

New drug mutes more melanomas

An experimental melanoma drug may be beneficial for patients not eligible for targeted therapies.
By VUMC News and Communications